Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | Journal of Inflammation

Fig. 4

From: MiRNA-494 enhances M1 macrophage polarization via Nrdp1 in ICH mice model

Fig. 4

MiR-494 regulated Nrdp1˛levels in vitro and in vivo (a) Nrdp1 is a direct target of miR-494 in macrophage. The region of the Nrdp1 mRNA 3’UTR predicted to be targeted by miR-494 as indicated. b Luciferase activity assays using reporters with wild-type or mutant Nrdp1 3’UTRs were performed after cotransfection with miR-494 mimics or control in macrophage. c Macrophages were transfected with miR-494 mimics or inhibitors. After 24 h, cells were harvested, and miR-494 levels were evaluated by qRT-PCR. Transduction of miR-494 mimics enhanced miR-494 mRNA levels, while transduction of miR-494 inhibitors decreased miR-494 mRNA levels. d Macrophages were transfected with miR-494 mimics or inhibitors, and then were treated with PBS or erythrocyte lysates for 3 days. After then, neuron was treated with conditioned medium from treated macrophage. After 48 h, the Nrdp1 expression of macrophages was analyzed by western blot assays. e Intracerebroventricular injection of miR-494 mimics or inhibitors was administered 10 min after ICH. miR-494 mimics significantly attenuated Nrdp1 levels compared with control group. Experiments performed in triplicate showed consistent results. The differences were analyzed using ANOVA. *P < 0.05

Back to article page